Telomerase Expression in Benign and Malignant Post-Menopausal Endometrium

Autor: RM Al-Jehani, IJ Jacobs

Publikováno v: Clinical Science. 97:9P-9P

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f2f1ce17329912ab64ff2791e2092bbc
https://doi.org/10.1042/cs097009pa

Factors influencing serum CA125II levels in healthy postmenopausal women

Autor: Dk, Pauler, Usha Menon, McIntosh M, Hl, Symecko, Sj, Skates, Ij, Jacobs

Publikováno v: Europe PubMed Central

Our objective was to identify factors that correlate with CA125 concentrations in healthy postmenopausal women and to introduce recommendations for reporting and interpreting individual CA125 assay results. We analyzed repeated serum CA125 levels, as

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::89fda62a60e2766f3e9bbcf116a1ae0f
http://europepmc.org/abstract/med/11352859

Novel treatment for PXE: Recombinant ENPP1 enzyme therapy.

Autor: Jacobs IJ; Department of Biochemistry and Molecular Biology, Sidney Kimmel Medical College, Jefferson Institute of Molecular Medicine, Thomas Jefferson University, Philadelphia, PA, USA; PXE International Center of Excellence in Research and Clinical Care, Thomas Jefferson University, Philadelphia, PA, USA., Obiri-Yeboah D; Department of Biochemistry and Molecular Biology, Sidney Kimmel Medical College, Jefferson Institute of Molecular Medicine, Thomas Jefferson University, Philadelphia, PA, USA; PXE International Center of Excellence in Research and Clinical Care, Thomas Jefferson University, Philadelphia, PA, USA., Stabach PR; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA., Braddock DT; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA., Li Q; Department of Biochemistry and Molecular Biology, Sidney Kimmel Medical College, Jefferson Institute of Molecular Medicine, Thomas Jefferson University, Philadelphia, PA, USA; PXE International Center of Excellence in Research and Clinical Care, Thomas Jefferson University, Philadelphia, PA, USA. Electronic address: qiaoli.li@jefferson.edu.

Publikováno v: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2024 Nov 06; Vol. 32 (11), pp. 3815-3820. Date of Electronic Publication: 2024 Sep 27.

Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trial.

Autor: Menon U; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. Electronic address: u.menon@ucl.ac.uk., Gentry-Maharaj A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK; Department of Women's Cancer, Elizabeth Garrett Anderson Institute for Women's Health, University College London, London, UK., Burnell M; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Ryan A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Singh N; Department of Cellular Pathology, Barts Health NHS Trust, London, UK., Manchanda R; Department of Gynaecological Oncology, Barts Health NHS Trust, London, UK; Wolfson Institute of Population Health, CRUK Barts Cancer Centre, Queen Mary University of London, London, UK., Kalsi JK; AGE Research Unit, School of Public Health Imperial College London, London, UK., Woolas R; Department of Gynaecological Oncology, Queen Alexandra Hospital, Portsmouth, UK., Arora R; Department of Cellular Pathology, University College London Hospitals NHS Trust, London, UK., Casey L; Department of Cellular Pathology, Barts Health NHS Trust, London, UK., Dawnay A; Department of Clinical Biochemistry, Barts Health NHS Trust, London, UK., Sharma A; Department of Obstetrics and Gynaecology, University Hospital of Wales, Cardiff, UK., Williamson K; Department of Gynaecological Oncology, Nottingham University Hospitals, Nottingham, UK., Apostolidou S; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Fallowfield L; Sussex Health Outcomes Research and Education in Cancer (SHORE-C), Brighton and Sussex Medical School, University of Sussex, Brighton, UK., McGuire AJ; London School of Economics and Political Science, London, UK., Campbell S; Create Health, London, UK., Skates SJ; Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Jacobs IJ; Department of Women's Cancer, Elizabeth Garrett Anderson Institute for Women's Health, University College London, London, UK., Parmar MKB; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2023 Sep; Vol. 24 (9), pp. 1018-1028.

Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial.

Autor: Menon U; MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK., Gentry-Maharaj A; MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK., Burnell M; MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK., Ryan A; MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK., Kalsi JK; Department of Women's Cancer, Institute for Women's Health, University College London, London, UK., Singh N; Department of Cellular Pathology, Barts Health NHS Trust, London, UK., Dawnay A; Department of Clinical Biochemistry, Barts Health NHS Service Trust, London, UK., Fallowfield L; Sussex Health Outcomes Research and Education in Cancer (SHORE-C), Brighton and Sussex Medical School, University of Sussex, Brighton, UK., McGuire AJ; London School of Economics and Political Science, London, UK., Campbell S; Create Health, London, UK., Skates SJ; Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Parmar M; MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK., Jacobs IJ; Department of Women's Health, University of New South Wales, Sydney, NSW, Australia.

Publikováno v: Health technology assessment (Winchester, England) [Health Technol Assess] 2023 May 11, pp. 1-81. Date of Electronic Publication: 2023 May 11.